3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Endometrial Neoplasms
13
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
3
Vulvar Neoplasms
2
Squamous Intraepithelial Lesions
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anus Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sezary Syndrome
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Interventions
pembrolizumab
9
Nivolumab
5
fludarabine
4
Cyclophosphamide
4
amatuximab
3
Ipilimumab
3
Fluorouracil
3
Cisplatin
3
tislelizumab
2
spartalizumab
2
budigalimab
2
belinostat
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cytoreduction Surgical Procedures
2
Carboplatin
2
venetoclax
1
talazoparib
1
rovalpituzumab tesirine
1
ribociclib
1
rebastinib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
epacadostat
1
durvalumab
1
bosutinib
1
atezolizumab
1
aldesleukin
1
Valacyclovir
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma
×
Observation
×
Gynecologic
×
Clear all
NCT02073500
2021-07-28
PSM
Oslo University Hospital
Recruiting
300 enrolled